Ipilimumab approved for metastatic melanoma
Read More
A chance meeting changes lives
JourneyForward.org
The website www.journeyforward.org was designed to help oncologists, primary care physicians and their patients improve their survivorship care.
Predicting Colorectal Cancer Recurrence
ColoPrint gene assay can help guide treatment options for some colorectal patients, study shows.
Transplants More Effective for Young Adults with AML
Adolescents with AML tend to do better with stem cell transplant.
Making plans for ASCO 2011
Donating 10 inches of hair takes a weight off my shoulders
Putting a face on colorectal cancer
Giving thanks: When a chocolate cake is more than just a dessert
Melanoma survivor shares how to have H.O.P.E. after cancer
Today is World Cancer Day
Make Valentine's Day special with these cards
New therapy regimen approved for advanced follicular lymphoma
CURE wins awards because of you
I don't know anything about cancer
Giving up my hair
Online Tool Helps Childhood Cancer Survivors Monitor Late Effects
Online tool helps cancer survivors know what to look for years after treatment
Cancer and Careers' updates workbook
Do you make new year's resolutions?
Rituxan May Replace Watch and Wait for Patients with Asymptomatic Follicular Lymphoma
Researchers showed that patients with nonsymptomatic, advanced follicular lymphoma (FL) benefit from Rituxan (rituximab) over watchful waiting.
Istodax Shows Benefit in T-Cell Lymphomas
A phase 2 trial presented at the American Society of Hematology in December could pave the way for a second approval for Istodax (romidepsin).
Phase 1 Trial of Ponatinib Shows Early Success in CML
Study shows experimental drug ponatinib acts against a mutation found in small percentage of chronic myeloid leukemia cases that is resistant to other forms of therapy
Pediatric Regimen Better for Young Adults with AML
Treatment differs for Acute myeloid leukemia pediatric patients compared with older adults.
Bosutinib Joins Crowd of CML-Focused Drugs
Chronic myeloid leukemia (CML)usually can be managed as a chronic disease by therapies, including Gleevec (imatinib) or two newer drugs, Sprycel (dasatinib) or Tasigna (nilotinib).
Two New Treatments Studied for Relapsed Hodgkin Lymphoma
For Hodgkin lymphoma patients who progress after a stem cell transplant, two new treatments may bring new hope.
Getting to the Core
Knowing the cellular basics drives treatment decisions.
Highlights
News and perspectives from the breast cancer community.
Genetic Screening for Lynch Syndrome Is Cost Effective
Widespread genetic testing of Lynch syndrome is cost-efficient and reduces the risk of colorectal cancer.
HER2-Targeted Combinations Look Promising
In the NeoSphere study, various combinations of a new HER2-targeted agent called pertuzumab, Herceptin and chemothery were studied in early-stage breast cancer patients with encouraging results.
Early access to novel drug for Hodgkin lymphoma patients is in the works